ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2307건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 | Active, not recruiting | Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection | Respiratory Viral Infection | Drug: Daily Vitamin D3 Drug: Daily placebo Drug: Bolus vitamin D3 Drug: Bolus placebo |
Phase 4 | Medical University of South Carolina, Grassroots Health Nutrition Institute, ZRT Laboratory | OTHER | 95 | All | 50 Years | Medical University of South Carolina, Charleston, South Carolina, United States |
| 10 | Completed | VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection | SARS-CoV-2 Infection | Biological: VLA2001 | Phase 3 | Valneva Austria GmbH | INDUSTRY | 178 | All | 18 Years | General Practitioners Research Institute (GPRI), Groningen, Netherlands European Clinical Research Alliance on Infectious Diseases (ECRAID), Utrecht, Netherlands Middlemore Clinical Trials, Auckland, Papatoetoe, New Zealand Optimal Clinical Trials, Auckland, New Zealand |
| 9 | Completed | Vortioxetine for Post-COVID-19 Condition | Cognitive Impairment | Drug: Vortioxetine Drug: Placebo |
Phase 2 | Brain and Cognition Discovery Foundation | OTHER | 200 | All | 18 Years | Brain and Cognition Discovery Foundation (BCDF), Toronto, Ontario, Canada |
| 8 | Terminated | Will Hydroxychloroquine Impede or Prevent COVID-19 | SARS-CoV 2 | Drug: Hydroxychloroquine - Daily Dosing Drug: Hydroxychloroquine - Weekly Dosing Other: Placebo oral tablet Diagnostic Test: Monitoring Visit - Baseline Diagnostic Test: Monitoring Visit - Week 4 Diagnostic Test: Monitoring Visit - Week 8 Other: Weekly Assessment |
Phase 3 | Henry Ford Health System | OTHER | 624 | All | 18 Years ~ 75 Years | Henry Ford Hospital, Detroit, Michigan, United States |
| 7 | Unknown status | World Health Organization (WHO) COVID-19 Solidarity Trial for COVID-19 Treatments | Covid19 | Drug: Remdesivir Drug: Acalabrutinib Drug: Interferon beta-1a Other: Standard of Care |
Phase 3 | The University of The West Indies | OTHER | 100 | All | 18 Years ~ 100 Years | Univeristy of the West Indies, Kingston, Jamaica |
| 6 | Suspended | Xanthohumol as an Adjuvant Therapy in Critically Ill COVID-19 Patients | COVID-19 Respiratory Infection | Biological: Xanthohumol - prenylated chalcone extracted from female inflorescences of hop cones (Humulus lupus). Hop-RXn™, BioActive-Tech Ltd, Lublin, Poland; http://xanthohumol.com.pl/ | Early Phase 1 | Medical University of Lublin | OTHER | 50 | All | 18 Years | Medical University of Lublin, Lublin, Poland |
| 5 | Suspended | Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19 | Chinese Medicine | Drug: YinHu QingWen Decoction Drug: YinHu QingWen Decoction(low dose) Other: Chinese medicine treatment Other: standard western medicine treatment |
Phase 3 | China Academy of Chinese Medical Sciences | OTHER | 300 | All | 18 Years | Jingzhou Hospital of Traditional Chinese Medicine, Jingzhou, Hubei, China Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei, China Xiangyang Hospital of Traditional Chinese Medicine, Xiangyang, Hubei, China |
